TY - JOUR
T1 - In-office procedures for the treatment of benign vocal fold lesions in the awake patient
T2 - A contemporary review
AU - Shoffel-Havakuk, Hagit
AU - Sadoughi, Babak
AU - Sulica, Lucian
AU - Johns, Michael M.
N1 - Publisher Copyright:
© 2018 The American Laryngological, Rhinological and Otological Society, Inc.
PY - 2019/9
Y1 - 2019/9
N2 - Objectives: To review available information regarding in-office procedures for benign vocal fold lesions (BVFL). Methods: PubMed term search on office/awake laryngeal procedures for any of the following specific lesions: Reinke's edema (RE), polyps, nodules, varices, vocal process granuloma, and vocal fold (VF) scar. Results: In-office ablative and nonablative laser procedures have been described for BVFL, including RE, polyps, varices, and granuloma. Fiber-based lasers used include potassium titanyl phosphate, pulsed dye laser, and more recently CO2. In-office intralesional steroid injection (ISI) for BVFL targets the inflammatory process involved with the lesion and may induce regression of polyps, nodules, RE, and granuloma. Botulinum toxin-induced “voice rest” has been described as adjunctive treatment for refractory VF nodules or vocal process granuloma. Most in-office techniques for treating BVFL rely on induction of lesion regression rather than complete lesion removal, as in conventional operative microsurgery. When treating VF scarring, in-office procedures aim to alter the wound-healing process; ISI targets the inflammatory phase and angiolytic lasers target the proliferative phase. Conclusion: In-office procedures for BVFL apply new technology that can potentially lower risk and cost. Although numerous case series have shown the potential of these procedures, data that thoroughly compares outcomes with those of microlaryngoscopic techniques is needed. Laryngoscope, 129:2131–2138, 2019.
AB - Objectives: To review available information regarding in-office procedures for benign vocal fold lesions (BVFL). Methods: PubMed term search on office/awake laryngeal procedures for any of the following specific lesions: Reinke's edema (RE), polyps, nodules, varices, vocal process granuloma, and vocal fold (VF) scar. Results: In-office ablative and nonablative laser procedures have been described for BVFL, including RE, polyps, varices, and granuloma. Fiber-based lasers used include potassium titanyl phosphate, pulsed dye laser, and more recently CO2. In-office intralesional steroid injection (ISI) for BVFL targets the inflammatory process involved with the lesion and may induce regression of polyps, nodules, RE, and granuloma. Botulinum toxin-induced “voice rest” has been described as adjunctive treatment for refractory VF nodules or vocal process granuloma. Most in-office techniques for treating BVFL rely on induction of lesion regression rather than complete lesion removal, as in conventional operative microsurgery. When treating VF scarring, in-office procedures aim to alter the wound-healing process; ISI targets the inflammatory phase and angiolytic lasers target the proliferative phase. Conclusion: In-office procedures for BVFL apply new technology that can potentially lower risk and cost. Although numerous case series have shown the potential of these procedures, data that thoroughly compares outcomes with those of microlaryngoscopic techniques is needed. Laryngoscope, 129:2131–2138, 2019.
KW - In-office procedures
KW - KTP
KW - benign vocal fold lesions
KW - laser
KW - steroid injection
UR - http://www.scopus.com/inward/record.url?scp=85058985880&partnerID=8YFLogxK
U2 - 10.1002/lary.27731
DO - 10.1002/lary.27731
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.systematicreview???
C2 - 30575043
AN - SCOPUS:85058985880
SN - 0023-852X
VL - 129
SP - 2131
EP - 2138
JO - Laryngoscope
JF - Laryngoscope
IS - 9
ER -